News & Updates

Stay informed about our latest breakthroughs and announcements.
Follow us on LinkedIn.

Brigid Bio's monoclonal antibody based immunotherapy approach has been featured in The Lancet's coverage of the Fungal Update: Mycology Conference 2026

May 7, 2026

Brigid Bio's monoclonal antibody based immunotherapy approach has been featured in The Lancet's coverage of the Fungal Update: Mycology Conference 2026

At Mycology Conference 2026, Prof Carol Munro presented promising preclinical data on our pan-fungal, first in class human monoclonal antibodies and their proven efficacy in invasive fungal infections in immunosuppressed and immunocompetent models. These antibodies are designed to target novel fungal cell wall proteins, present in Candida and Aspergillus spp representing a significant breakthrough in the fight against invasive fungal infections.

Brigid Bio Co-Founders Honoured at University of Aberdeen Principal’s Excellence Awards

April 23, 2026

Brigid Bio Co-Founders Honoured at University of Aberdeen Principal’s Excellence Awards

The co-founders of Brigid Bio Ltd - Professor Carol Munro, Dr Soumya Palliyil, and Professor Andy Porter - have been recognised at the prestigious University of Aberdeen Principal’s Excellence Awards for their outstanding contributions to scientific research and entrepreneurship.

Brigid Bio to attend 10th AMR Conference in Basel 3-4th March 2026!

February 24, 2026

Brigid Bio to attend 10th AMR Conference in Basel 3-4th March 2026!

Brigid Bio is excited to announce attendance at the 10th Antimicrobial Resistance (AMR) Conference in Basel 3-4th March 2026, a leading event for innovators in anti-infectives.

Brigid Bio sparks Industry-Academia dialogue at Leibniz-HKI’s Innovations in Antifungal Drug Development, Jena Germany

February 3, 2026

Brigid Bio sparks Industry-Academia dialogue at Leibniz-HKI’s Innovations in Antifungal Drug Development, Jena Germany

Brigid Bio was honoured to be invited to present at the symposium “Innovations in Antifungal Drug Development – An Industry-Academia Dialogue” organised by Leibniz-HKI, bringing together industry leaders and academic experts to advance innovation in antifungal therapeutics.

Brigid Bio joins BEAM Alliance to strengthen the fight against Antimicrobial Resistance.

December 11, 2025

Brigid Bio joins BEAM Alliance to strengthen the fight against Antimicrobial Resistance.

Brigid Bio was honoured to be invited to present at the symposium “Innovations in Antifungal Drug Development – An Industry-Academia Dialogue” organised by Leibniz-HKI, bringing together industry leaders and academic experts to advance innovation in antifungal therapeutics.

Brigid Bio are headline winners in the Scottish EDGE finals

December 5, 2025

Brigid Bio are headline winners in the Scottish EDGE finals #EDGE26!.

Brigid Bio is delighted to announce winning the top national Scottish EDGE award...

Brigid Bio featured in successful Scottish Enterprise High Growth Spinout case study!

November 14, 2025

Spinning out science: how we are helping Brigid Bio go from lab to market

Brigid Bio is proud to be featured in this article as a Scottish Enterprise High Growth Spinout case study!...

Brigid Bio awarded INCATE Stage II Funding

August 1, 2025

Brigid Bio awarded INCATE Stage II Funding

Brigid Bio has been selected as an INCATE Stage II venture, securing non-dilutive funding...

University of Aberdeen launches new spin-out Brigid Bio

July 28, 2025

University of Aberdeen launches new spin-out Brigid Bio

Our latest research has led to significant breakthroughs in sustainable bio-production methods...

Get In Touch

If you would like further information about our solution, please get in contact with us.

We would love to hear from Oncologists, Infectious Disease Consultants, and R&D specialists within the Biotech and Pharma industries.

Connect on LinkedIn

Brigid Bio, Liberty Building
Foresterhill Health Campus
Foresterhill Rd, Aberdeen AB25 2ZP